Issues: Vax Specific

Anthrax

Hepatitis B

Hib

Influenza

Lyme Disease
Meningococcal

MMR    

Pneumococcal

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

 

Vaccine Info

● 2012 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

DTaP/Tdap/Td VACCINE

Study supports current recommendations to administer intramuscular DTaP vaccines in the thigh (not arm) of children younger than 3 years.  Jackson LA et al.  Pediatrics 2013.  link to abstract

ACIP updates recommendations to include Tdap for all adults 65 years and older. (MMWR 6-29-12) [link]

Td or Tdap – CDC’s Vaccine Information Statement, dated January 24, 2012 [link]

ACIP updates use of Tdap in Pregnant Women and those with close contact with children younger than a year.  (MMWR 10-21-11) [link]

Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Accellular Pertussis (Tdap) Vaccine from the ACIP, 2010 [link] MMWR 2011;60(01):13. (1-14-11)

DTaP - CDC’s Vaccine Information Statement, dated May 17, 2007 (http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-dtap.pdf)

 

Older Information

Boostrix, a booster DT acellular pertussis vaccine, has been approved for 10-18 year olds.  This is the first licensed acellular pertussis-containing vaccine indicated for adolescents. 

 

 

This page was last updated on February 11, 2013

© 2013 Institute for Vaccine Safety